Non-preserved topical corticosteroid for treatment of dry eye, filamentary keratitis, and delayed tear clearance (or turnover)
US6153607A · kind A · utility
141Cited by
9References
7Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 4, 1996 |
| Grant date | Nov 28, 2000 |
| Priority date | — |
| Expiry date | Dec 4, 2016 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K31/58
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A preservative-free composition containing an effective amount of a corticosteroid in an aqueous carrier to treat a dry eye condition. The composition may be provided as a part of a therapeutic regimen to treat a variety of dry eye conditions and ocular surface disorders manifesting delayed tear clearance previously not readily treatable. The composition may be packaged as containers of single dosage amounts of the corticosteroid-aqueous composition sufficient for pulsed-therapy of acute exacerbations of the irritation symptoms and ocular surface disease of conditions associated with dry eye and delayed tear clearance.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.